Synapse - Laura Tang

Results (131)

Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)

Meeting Abstract

O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Comprehensive molecular characterization of gastric adenocarcinoma

Journal Article

The Cancer Genome Atlas Research Network
Nature (2014)

Fulltext@MSK | Save

Retrospective review of patients with metastatic high grade neuroendocrine carcinoma of the pancreas: Memorial Sloan-Kettering Cancer Center experience (MSKCC)

Meeting Abstract

Shum, E.; Basturk, O.; Klimstra, D.; Tang, L. H.; Capanu, M.; Reidy-Lagunes, D. L.
Pancreas (2014)

Fulltext@MSK | Save

A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma

Journal Article

O'Reilly, E. M.; Perelshteyn, A.; Jarnagin, W. R.; Schattner, M.; Gerdes, H.; Capanu, M.; Tang, L. H.; Lavalle, J.; Winston, C.; DeMatteo, R. P.; more...
Annals of Surgery (2014)

Fulltext@MSK | Save

Evaluation of PET response to neoadjuvant therapy for patients with gastric and GEJ adenocarcinoma

Meeting Abstract

Hernandez, J. M.; Beylergil, V.; Goldman, D.; Schoder, H.; Gonen, M.; Tang, L. H.; Downey, R. J.; Shah, M. A.; Strong, V. E.; Coit, D. G.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Evaluation of PET response to neoadjuvant therapy for patients with gastric and GEJ adenocarcinoma

Meeting Abstract

Hernandez, J.; Beylergil, V.; Goldman, D.; Tang, L. H.; Ilson, D. H.; Downey, R.; Strong, V. E.; Shah, M.; Gonen, M.; Schoder, H.; more...
Annals of Surgical Oncology (2014)

Fulltext@MSK | Save

Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma

Journal Article

Bamboat, Z. M.; Tang, L. H.; Vinuela, E.; Kuk, D.; Gonen, M.; Shah, M. A.; Brennan, M. F.; Coit, D. G.; Strong, V. E.
Annals of Surgical Oncology (2014)

Fulltext@MSK | Save

Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma

Meeting Abstract

Ku, G. Y.; Janjigian, Y. Y.; Shah, M. A.; Herrera, J.; Tang, L. H.; Fuqua, L.; Capanu, M.; Ilson, D.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)